Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 20 May 2009, doi:10.1136/bmj.b2055
Cite this as: BMJ 2009;338:b2055
Deborah Cohen
1 BMJ
| The first 150 words of the full text of this article appear below. |
The United Kingdoms drugs agency has given a licence to the makers of a homoeopathic product, despite scientists and researchers saying that no evidence shows that it works.
Since September 2006 the Medicines and Healthcare Products Regulatory Agency (MHRA) has been allowed to grant licences to traditional therapies if their use "is plausible on the basis of long standing use and experience" and no evidence shows that they cause harm.
At the end of last month, Nelsons Arnicare Arnica 30c pillules became the first product in the UK to be given such a licence by the agency, which will enable its manufacturers to make therapeutic claims for it.
Edzard Ernst, the UKs only professor of complementary medicine, said that the agencys national rules scheme was "making a mockery of evidence based medicine."
On the packaging, the makers will be able to describe the product as "a homoeopathic medicinal product used
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses